Cationic surface charge combined with either vitronectin or laminin dictates the evolution of human embryonic stem cells/microcarrier aggregates and cell growth in agitated cultures

Stem Cells and Development

Volumn 23, Issue 14, 2014, Pages 1688-1703

  Lam, Alan Tin Lun ^a   Li, Jian ^b   Chen, Allen Kuan Liang ^a   Reuveny, Shaul ^a   Oh, Steve Kah Weng ^a   Birch, William R ^b  

^a AGENCY FOR SCIENCE   (Singapore)

^b INSTITUTE OF MATERIALS RESEARCH AND ENGINEERING   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

LAMININ; MICROSPHERE; POLYLYSINE; POLYSTYRENE; SCLEROPROTEIN; VITRONECTIN; CULTURE MEDIUM; LYSINE;

AGITATION; ARTICLE; CELL ANCHORAGE; CELL DIFFERENTIATION; CELL EXPANSION; CELL GROWTH; CELL SPREADING; CELL VIABILITY; CONTROLLED STUDY; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROCARRIER CULTURE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCALE UP; SURFACE CHARGE; SURFACE PROPERTY; ZETA POTENTIAL; BIOREACTOR; CELL PROLIFERATION; CHEMISTRY; COATED VESICLE; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; METABOLISM; PLURIPOTENT STEM CELL; TUMOR MICROENVIRONMENT;

BIOREACTORS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLULAR MICROENVIRONMENT; COATED VESICLES; CULTURE MEDIA, SERUM-FREE; EMBRYONIC STEM CELLS; EXTRACELLULAR MATRIX; HUMANS; LAMININ; LYSINE; MICROSPHERES; PLURIPOTENT STEM CELLS; VITRONECTIN;

EID: 84904100771     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0645     Document Type: Article

References (76)

1. Kobayashi S, T Takebe, M Inui, S Iwai, H Kan, YW Zheng, J Maegawa and H Taniguchi. (2011). Reconstruction of human elastic cartilage by a CD44+ CD90+ stem cell in the ear perichondrium. Proc Natl Acad Sci U S A 108: 14479-14484.
2. Kriks S, JW Shim, J Piao, YM Ganat, DR Wakeman, Z Xie, L Carrillo-Reid, G Auyeung, C Antonacci, et al. (2011). Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480:547-551.
3. Lu SJ, F Li, H Yin, Q Feng, EA Kimbrel, E Hahm, JN Thon, W Wang, JE Italiano, J Cho and R Lanza. (2011). Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res 21:530-545.
4. Schwartz SD, JP Hubschman, G Heilwell, V Franco- Cardenas, CK Pan, RM Ostrick, E Mickunas, R Gay, I Klimanskaya and R Lanza. (2012). Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet 379:713-720.
5. Segers VF and RT Lee. (2008). Stem-cell therapy for cardiac disease. Nature 451:937-942.
6. Chun YS, K Byun and B Lee. (2011). Induced pluripotent stem cells and personalized medicine: current progress and future perspectives. Anat Cell Biol 44:245-255.
7. Bardy J, AK Chen, YM Lim, S Wu, S Wei, H Weiping, K Chan, S Reuveny and SK Oh. (2013). Microcarrier suspension cultures for high-density expansion and differentiation of human pluripotent stem cells to neural progenitor cells. Tissue Eng Part C Methods 19:166-180.
8. Lecina M, S Ting, A Choo, S Reuveny and S Oh. (2010). Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures. Tissue Eng Part C Methods 16:1609-1619.
9. Leung HW, A Chen, AB Choo, S Reuveny and SK Oh. (2011). Agitation can induce differentiation of human pluripotent stem cells in microcarrier cultures. Tissue Eng Part C Methods 17:165-172.
10. Lock LT and ES Tzanakakis. (2009). Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture. Tissue Eng Part A 15:2051-2063.
11. Chen AK, S Reuveny and SK Oh. (2013). Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction. Biotechnol Adv 31:1032-1046.
12. Kehoe DE, D Jing, LT Lock and ES Tzanakakis. (2010). Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng Part A 16:405-421.
13. Nie Y, V Bergendahl, DJ Hei, JM Jones and SP Palecek. (2009). Scalable culture and cryopreservation of human embryonic stem cells on microcarriers. Biotechnol Prog 25: 20-31.
14. Oh SK, AK Chen, Y Mok, X Chen, UM Lim, A Chin, AB Choo and S Reuveny. (2009). Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Res 2:219-230.
15. Serra M, C Brito, MF Sousa, J Jensen, R Tostoes, J Clemente, R Strehl, J Hyllner, MJ Carrondo and PM Alves. (2010). Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. J Biotechnol 148:208-215.
16. Marinho PA, DT Vareschini, IC Gomes, S Paulsen Bda, DR Furtado, R Castilho Ldos and SK Rehen. (2013). Xeno-free production of human embryonic stem cells in stirred microcarrier systems using a novel animal/human-component-free medium. Tissue Eng Part C Methods 19:146-155.
17. Phillips BW, R Horne, TS Lay, WL Rust, TT Teck and JM Crook. (2008). Attachment and growth of human embryonic stem cells on microcarriers. J Biotechnol 138:24-32.
18. Heng BC, J Li, AK Chen, S Reuveny, SM Cool, WR Birch and SK Oh. (2012). Translating human embryonic stem cells from 2-dimensional to 3-dimensional cultures in a defined medium on laminin- and vitronectin-coated surfaces. Stem Cells Dev 21:1701-1715.
19. Newman KD and MW McBurney. (2004). Poly(D,L lactic-co-glycolic acid) microspheres as biodegradable microcarriers for pluripotent stem cells. Biomaterials 25: 5763-5771.
20. Domogatskaya A, S Rodin and K Tryggvason. (2012). Functional diversity of laminins. Annu Rev Cell Dev Biol 28:523-553.
21. Timpl R, H Rohde, PG Robey, SI Rennard, JM Foidart and GR Martin. (1979). Laminin-a glycoprotein from basement membranes. J Biol Chem 254:9933-9937.
22. Aumailley M, L Bruckner-Tuderman, WG Carter, R Deutzmann, D Edgar, P Ekblom, J Engel, E Engvall, E Hohenester, et al. (2005). A simplified laminin nomenclature. Matrix Biol 24:326-332.
23. Colognato H and PD Yurchenco. (2000). Form and function: the laminin family of heterotrimers. Dev Dyn 218: 213-234.
24. Miyazaki T, S Futaki, K Hasegawa, M Kawasaki, N Sanzen, M Hayashi, E Kawase, K Sekiguchi, N Nakatsuji and H Suemori. (2008). Recombinant human laminin isoforms can support the undifferentiated growth of human embryonic stem cells. Biochem Biophy Res Co 375:27-32.
25. Chen AK, X Chen, AB Choo, S Reuveny and SK Oh. (2011). Critical microcarrier properties affecting the expansion of undifferentiated human embryonic stem cells. Stem Cell Res 7:97-111.
26. Domogatskaya A, S Rodin, A Boutaud and K Tryggvason. (2008). Laminin-511 but not -332, -111, or -411 enables mouse embryonic stem cell self-renewal in vitro. Stem Cells 26:2800-2809.
27. Rodin S, A Domogatskaya, S Strom, EM Hansson, KR Chien, J Inzunza, O Hovatta and K Tryggvason. (2010). Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat Biotechnol 28:611-615.
28. Miyazaki T, S Futaki, H Suemori, Y Taniguchi, M Yamada, M Kawasaki, M Hayashi, H Kumagai, N Nakatsuji, K Sekiguchi and E Kawase. (2012). Laminin E8 fragments support efficient adhesion and expansion of dissociated human pluripotent stem cells. Nat Commun 3:1236.
29. Schvartz I, D Seger and S Shaltiel. (1999). Vitronectin. Int J Biochem Cell Biol 31:539-544.
30. Bueno EM, G Laevsky and GA Barabino. (2007). Enhancing cell seeding of scaffolds in tissue engineering through manipulation of hydrodynamic parameters. J Biotechnol 129:516-531.
31. Rowland TJ, LM Miller, AJ Blaschke, EL Doss, AJ Bonham, ST Hikita, LV Johnson and DO Clegg. (2010). Rolesof integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin. Stem Cells Dev 19:1231-1240.
32. Braam SR, L Zeinstra, S Litjens, D Ward-van Oostwaard, S van den Brink, L van Laake, F Lebrin, P Kats, R Hochstenbach, et al. (2008). Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin. Stem Cells 26:2257-2265.
33. Li J, J Bardy, LY Yap, A Chen, V Nurcombe, SM Cool, SK Oh and WR Birch. (2010). Impact of vitronectin concentration and surface properties on the stable propagation of human embryonic stem cells. Biointerphases 5:FA132- FA142.
34. Yap LY, J Li, IY Phang, LT Ong, JZ Ow, JC Goh, V Nurcombe, J Hobley, AB Choo, et al. (2011). Defining a threshold surface density of vitronectin for the stable expansion of human embryonic stem cells. Tissue Eng Part C Methods 17:193-207.
35. Abbasalizadeh S, MR Larijani, A Samadian and H Baharvand. (2012). Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor. Tissue Eng Part C Methods 18:831-851.
36. Serra M, C Brito, C Correia and PM Alves. (2012). Process engineering of human pluripotent stem cells for clinical application. Trends Biotechnol 30:350-359.
37. Chisti Y. (2001). Hydrodynamic damage to animal cells. Crit Rev Biotechnol 21:67-110.
38. Hua J, LE Erickson, TY Yiin and LA Glasgow. (1993). A review of the effects of shear and interfacial phenomena on cell viability. Crit Rev Biotechnol 13:305-328.
39. Al-Rubeai M, RP Singh, MH Goldman and AN Emery. (1995). Death mechanisms of animal cells in conditions of intensive agitation. Biotechnol Bioeng 45:463-472.
40. Kretzmer G. (2000). Influence of stress on adherent cells. Adv Biochem Eng Biotechnol 67:123-137.
41. Kinney MA, CY Sargent and TC McDevitt. (2011). The multiparametric effects of hydrodynamic environments on stem cell culture. Tissue Eng Part B Rev 17:249-262.
42. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
43. Chin AC, J Padmanabhan, SK Oh and AB Choo. (2010). Defined and serum-free media support undifferentiated human embryonic stem cell growth. Stem Cells Dev 19: 753-761.
44. Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
45. Ng YC, JM Berry and M Butler. (1996). Optimization of physical parameters for cell attachment and growth on macroporous microcarriers. Biotechnol Bioeng 50:627-635.
46. Choo AB, HL Tan, SN Ang, WJ Fong, A Chin, J Lo, L Zheng, H Hentze, RJ Philp, SK Oh and M Yap. (2008). Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. Stem Cells 26:1454-1463.
47. Maecker HT and J Trotter. (2006). Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A 69:1037-1042.
48. Lian X, C Hsiao, G Wilson, K Zhu, LB Hazeltine, SM Azarin, KK Raval, J Zhang, TJ Kamp and SP Palecek. (2012). Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A 109:E1848-E1857.
49. Wang C, Y Gong, Y Lin, J Shen and DA Wang. (2008). A novel gellan gel-based microcarrier for anchorage-dependent cell delivery. Acta Biomater 4:1226-1234.
50. Stathopoulos NA and JD Hellums. (1985). Shear stress effects on human embryonic kidney cells in Vitro. Biotechnol Bioeng 27:1021-1026.
51. Yurchenco PD, EC Tsilibary, AS Charonis and H Furthmayr. (1985). Laminin polymerization in vitro. Evidence for a two-step assembly with domain specificity. J Biol Chem 260:7636-7644.
52. Nomizu M, A Utani, K Beck, A Otaka, PP Roller and Y Yamada. (1996). Mechanism of laminin chain assembly into a triple-stranded coiled-coil structure. Biochemistry 35:2885-2893.
53. Sasaki T, R Fassler and E Hohenester. (2004). Laminin: the crux of basement membrane assembly. J Cell Biol 164: 959-963.
54. Onuma K and N Kanzaki. (2005). Aggregation dynamics of laminin-1 in a physiological solution: A time-resolved static light scattering study. Journal of Crystal Growth 284: 530-537.
55. Onuma K and N Kanzaki. (2003). Size Distribution and Intermolecular Interaction of Laminin-1 in Physiological Solutions. J Phy Chem 107:11799-11804.
56. Izumi M, KM Yamada and M Hayashi. (1989). Vitronectin exists in two structurally and functionally distinct forms in human plasma. Biochim Biophys Acta 990:101-108.
57. Zhang H, K Bremmell, S Kumar and RS Smart. (2004). Vitronectin adsorption on surfaces visualized by tapping mode atomic force microscopy. J Biomed Mater Res A 68:479-488.
58. Janas T. (2011). Membrane oligo- and polysialic acids. Biochim Biophys Acta 1808:2923-2932.
59. Stern E, R Wagner, FJ Sigworth, R Breaker, TM Fahmy and MA Reed. (2007). Importance of the Debye screening length on nanowire field effect transistor sensors. Nano Lett 7:3405-3409.
60. Morgan MR, MJ Humphries and MD Bass. (2007). Synergistic control of cell adhesion by integrins and syndecans. Nat Rev Mol Cell Bio 8:957-969.
61. Lambaerts K, SA Wilcox-Adelman and P Zimmermann. (2009). The signaling mechanisms of syndecan heparan sulfate proteoglycans. Curr Opin Cell Biol 21:662-669.
62. Grinnell F. (1978). Cellular adhesiveness and extracellular substrata. Int Rev Cytol 53:65-144.
63. Plow EF, TA Haas, L Zhang, J Loftus and JW Smith. (2000). Ligand binding to integrins. J Biol Chem 275: 21785-21788.
64. Lynn GW, WT Heller, A Mayasundari, KH Minor and CB Peterson. (2005). A model for the three-dimensional structure of human plasma vitronectin from small-angle scattering measurements. Biochemistry 44:565-574.
65. Preissner KT, E Anders, J Grulich-Henn and G Muller- Berghaus. (1988). Attachment of cultured human endothelial cells is promoted by specific association with S protein (vitronectin) as well as with the ternary S proteinthrombin- antithrombin III complex. Blood 71:1581-1589.
66. Nishiuchi R, J Takagi, M Hayashi, H Ido, Y Yagi, N Sanzen, T Tsuji, M Yamada and K Sekiguchi. (2006). Ligand-binding specificities of laminin-binding integrins: A comprehensive survey of laminin-integrin interactions using recombinant alpha3beta1, alpha6beta1, alpha7beta1 and alpha6beta4 integrins. Matrix Biol 25:189-197.
67. Rao NC, SH Barsky, VP Terranova and LA Liotta. (1983). Isolation of a tumor cell laminin receptor. Biochem Biophys Res Commun 111:804-808.
68. Nelson J, NV McFerran, G Pivato, E Chambers, C Doherty, D Steele and DJ Timson. (2008). The 67 kDa laminin receptor: structure, function and role in disease. Biosci Rep 28:33-48.
69. Kurosawa H. (2012). Application of Rho-associated protein kinase (ROCK) inhibitor to human pluripotent stem cells. J Bio Bioeng 114:577-581.
70. Watanabe K, M Ueno, D Kamiya, A Nishiyama, M Matsumura, T Wataya, JB Takahashi, S Nishikawa, K Muguruma and Y Sasai. (2007). A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nature Biotechnol 25:681-686.
71. Heng YW and CG Koh. (2010). Actin cytoskeleton dynamics and the cell division cycle. Int J Biochem Cell Biol 42:1622-1633.
72. Votteler M, PJ Kluger, H Walles and K Schenke-Layland. (2010). Stem cell microenvironments-unveiling the secret of how stem cell fate is defined. Macromol Biosci 10:1302-1315.
73. Brizzi MF, G Tarone and P Defilippi. (2012). Extracellular matrix, integrins, and growth factors as tailors of the stem cell niche. Curr Opin Cell Biol 24:645-651.
74. Peerani R, BM Rao, C Bauwens, T Yin, GA Wood, A Nagy, E Kumacheva and PW Zandstra. (2007). Nichemediated control of human embryonic stem cell selfrenewal and differentiation. EMBO J 26:4744-4755.
75. Davey RE and PW Zandstra. (2006). Spatial organization of embryonic stem cell responsiveness to autocrine gp130 ligands reveals an autoregulatory stem cell niche. Stem Cells 24:2538-2548.
76. Lian X, J Zhang, SM Azarin, K Zhu, LB Hazeltine, X Bao, C Hsiao, TJ Kamp and SP Palecek. (2013). Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions. Nat Protoc 8:162-175.